Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Cancer Health Center

Font Size

Tumor-Melting Virus vs. Prostate Cancer

Reovirus Is Harmless -- Except to Many Kinds of Cancers


One way of overcoming this problem is by using reovirus together with chemotherapy. Chemo kills cancer cells, but also dampens antiviral immune responses. A recent human study shows this strategy can benefit patients with advanced head and neck cancer.

Another way to overcome the problem is to harness anti-reovirus immune responses to attack cancer cells.

"The virus only sticks to tumor cells, so it sort of directs the immune response to the tumor area," Morris says. "We have actually taken reovirus and injected it in combination with tumor antigens, so the immune system kills tumors pasted with the virus."

There's still a lot of work to do before reovirus in general, or Reolysin in particular, becomes an approved cancer treatment, says cancer expert Rameen Beroukhim, MD, PhD. Beroukhim was not involved in the Morris study.

"There is a long way between this interesting study and showing that reovirus is going to be beneficial to patients," Beroukhim says. "But the hope is that this treatment could be tweaked in some way to have a systemic anti-cancer effect."

Morris is the first to acknowledge that there's a lot more work to do. One major issue, he says, is that not every patient's cancer is susceptible to reovirus.

"In the majority of cancers, if you take specimens from different patients, not all cancers are killed. Maybe seven or eight of 10 patients' cancers are sensitive. So we need to find out what makes a cancer cell susceptible to reovirus," he says.

The Morris study was partially funded by Oncolytics Biotech, and the company funds his laboratory. But Morris says he has not been compensated by any companies in the oncology-virus field for the last five years. Although he is a patent holder on some indications for reovirus, he has signed away rights to financial gain.

Morris and colleagues report their findings in the March 15 issue of Cancer Research.

1 | 2

Today on WebMD

Colorectal cancer cells
New! I AM Not Cancer Facebook Group
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Real Cancer Perspectives
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas